NeuroPace Seeks $75M In IPO
The California neuromodulation company filed a registration with the US Securities and Exchange Commission to sell common stock on NASDAQ under the ticker NPCE.
You may also be interested in...
The latest financing round will also support a new clinical trial of the RNS system for children with epilepsy.
The American Medical Association has written a set of principles for augmented intelligence (AI) development and deployment in health care. The organization hopes these principles can shape “a consistent governance structure for advancements in health care technology.”
Medtech Insight's News We're Watching highlights medtech industry news developments you may have missed over the last few weeks.